EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Suppression of colorectal cancer growth: Interplay between curcumin and metformin through DMT1 downregulation and ROS ‐mediated pathways

Hui-Yen Chuang iD, Hui-Wen Chan, Kuang-Chung Shih

BioFactors · 2025

DOI: 10.1002/biof.2137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioFactors, 2025. Verfasst von Hui-Yen Chuang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Curcumin, Colorectal Neoplasms, Reactive Oxygen Species, Metformin. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rising incidence of colorectal cancer (CRC) poses significant healthcare challenges. This study explored the therapeutic potential of combined curcumin (CUR) and metformin (MET) treatment in CRC models. Our findings indicate that the combination treatment (COMB) effectively downregulates the expression of divalent metal transporter‐1 (DMT‐1), leading to a reduction in cell proliferation aligned with suppression of the pAKT/mTOR/Cyclin D1 signaling pathway. The COMB increased reactive oxygen species (ROS) production, triggering activation of the NRF2/KEAP1 pathway. This pathway elicits an antioxidant response to manage oxidative stress in CRC cell lines. Interestingly, the response of NRF2 varied between CT26 and HCT116 cells. Moreover, our study highlights the induction of apoptosis and autophagy, as evidenced by upregulations in Bax/Bcl‐2 ratios and autophagy‐related protein expressions. Notably, the COMB promoted lipid peroxidation and downregulated xCT levels, suggesting the induction of ferroptosis. Ferroptosis has been shown to activate autophagy, which helps eliminate cells potentially damaged by the increased oxidative stress. Furthermore, the COMB effectively diminished the migratory ability of CRC cells. In vivo experiments using CRC‐bearing mouse models, the results confirmed the anti‐tumor efficacy of the COMB, leading to substantial inhibition of tumor growth without inducing general toxicity. In conclusion, our study suggests that combining CUR with MET holds promise as a potential option for CRC treatment, with critical mechanisms likely involving ROS elevation, autophagy, and ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminColorectal NeoplasmsReactive Oxygen SpeciesMetforminCell ProliferationHumansAnimalsMiceApoptosisSignal TransductionAutophagyOxidative StressDown-RegulationCell Line, TumorHCT116 CellsNF-E2-Related Factor 2Amino Acid Transport System y+Xenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticFerroptosisMice, Inbred BALB C

Stichwörter der Autor:innen

DMT1ROSautophagycolorectal cancercurcuminferroptosismetformin

Substanzen

CurcuminReactive Oxygen SpeciesMetforminSLC7A11 protein, humanNF-E2-Related Factor 2Amino Acid Transport System y+

Autor:innen und Institutionen

  • Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Division of Endocrinology and Metabolism, Department of Medicine, Cheng-Hsin General Hospital, Taipei, Taiwan.
  • Division of Endocrinology & Metabolism, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • School of Medicine, National Defense Medical Center, Taipei, Taiwan.

ORCID-Profile: Hui-Yen Chuang

Förderung

  • National Science and Technology Council

Zitieren

APA

Chuang, H. Y., Chan, H. W., & Shih, K. C. (2025). Suppression of colorectal cancer growth: Interplay between curcumin and metformin through DMT1 downregulation and ROS ‐mediated pathways. BioFactors. https://doi.org/10.1002/biof.2137

Vancouver

Chuang HY, Chan HW, Shih KC. Suppression of colorectal cancer growth: Interplay between curcumin and metformin through DMT1 downregulation and ROS ‐mediated pathways. BioFactors. 2025. doi:10.1002/biof.2137

BibTeX
@article{Chuang2025,
  author = {Chuang, Hui-Yen and Chan, Hui-Wen and Shih, Kuang-Chung},
  title = {Suppression of colorectal cancer growth: Interplay between curcumin and metformin through DMT1 downregulation and ROS ‐mediated pathways},
  journal = {BioFactors},
  year = {2025},
  doi = {10.1002/biof.2137}
}
Kostenlos starten →